IMMUNO-COV™ – The Test for Antibodies that Block SARS-CoV-2 Infection Read More

June 26-28, 2018

Armed Oncolytic Immunotherapies Summit

Stephen J. Russell, M.D., Ph.D., Vyriad President and Chief Executive Officer
Presentation: “Systemic Cancer Therapy Using Oncolytic VSVs: The Voyager Platform”
Dr. Russell will participate in a panel discussion, “Explore Novel Approaches to Identify the Most Rational Combinations“

Visit event site

Media Inquiries

For inquiries, please contact mediarelations@vyriad.com